Oncotarget
The cover for issue 1 of Oncotarget features Figure 2, "Results in clinical trials," by Blagoev, et al.
Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors |
https://doi.org/10.18632/oncotarget.27861 Erika J. Crosby, H. Kim Lyerly, and Zachary C. Hartman |
1-3 |
PDF | How to cite | Order a Reprint |
Carving a niche for immunotherapy in ovarian cancer |
https://doi.org/10.18632/oncotarget.27864 Nitasha Gupta, Erika Lampert, and Jung-Min Lee |
4-7 |
PDF | How to cite | Order a Reprint |
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy |
https://doi.org/10.18632/oncotarget.27865 Adam M. Sonabend, Roger Stupp, Catalina Lee-Chang, and Hideho Okada |
8-9 |
PDF | How to cite | Order a Reprint |
Combination therapies for MPNSTs targeting RABL6A-RB1 signaling |
https://doi.org/10.18632/oncotarget.27862 Jordan L. Kohlmeyer, David J. Gordon, Munir R. Tanas, Rebecca D. Dodd, Varun Monga, Benjamin W. Darbro, and Dawn E. Quelle |
10-14 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer |
https://doi.org/10.18632/oncotarget.27855 Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo, and Susan E. Bates |
15-21 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment |
https://doi.org/10.18632/oncotarget.27859 Juyeon Ko, April N. Meyer, Martin Haas, and Daniel J. Donoghue |
22-36 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model |
https://doi.org/10.18632/oncotarget.27857 Gerrit Spanier, Daniela Weidt, Dirk Hellwig, Johannes K.H. Meier, Torsten E. Reichert, and Jirka Grosse |
37-48 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation |
https://doi.org/10.18632/oncotarget.27858 Karim Abid, Maja Beck Popovic, Katia Balmas Bourloud, Jacqueline Schoumans, Joana Grand-Guillaume, Eric Grouzmann, and Annick Mühlethaler-Mottet |
49-60 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals |
https://doi.org/10.18632/oncotarget.27638 Pengjun Zhou, Rong Zhang, Ying Wang, Dandan Xu, Li Zhang, Jinhong Qin, Guifeng Su, Yue Feng, Hongce Chen, Siyuan You, Wen Rui, Huizhong Liu, Suhong Chen, Hongyuan Chen, and Yifei Wang |
61-62 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC